Gene Editing Stocks Might Be Building Some Momentum

Experienced healthcare and biotechnology investors know that January brings the arrival of the widely followed JPMorgan healthcare conference. This year, it’s taking place in virtual fashion, but that’s not preventing the event from stoking the usual chatter and optimism directed at...